Aisling Capital

Latest statistics and disclosures from Aisling Capital's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are Aimmune Therapeutics, ADMA, CDTX, Transenterix, VRAYQ, and represent 100.00% of Aisling Capital's stock portfolio.
  • Added to shares of these 1 stock: VRAYQ.
  • Started 1 new stock position in VRAYQ.
  • Reduced shares in these 2 stocks: Aimmune Therapeutics (-$16M), CDTX.
  • Aisling Capital was a net seller of stock by $-16M.
  • Aisling Capital has $45M in assets under management (AUM), dropping by -24.94%.
  • Central Index Key (CIK): 0001571076

Tip: Access up to 7 years of quarterly data

Positions held by Aisling Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Aisling Capital

Aisling Capital holds 5 positions in its portfolio as reported in the September 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Aimmune Therapeutics 57.3 $26M -37% 1.2M 20.94
 View chart
Adma Biologics (ADMA) 35.5 $16M 3.6M 4.45
 View chart
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) 3.9 $1.8M -12% 892k 2.00
 View chart
Transenterix 3.3 $1.5M 2.4M 0.62
 View chart
Viewray (VRAYQ) 0.0 $0 NEW 19k 0.00
 View chart

Past Filings by Aisling Capital

SEC 13F filings are viewable for Aisling Capital going back to 2013

View all past filings